Paper Review Records
全部论文审稿周期
21 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
19
天
Small-molecule ferroptosis inducers and sensitizers in anticancer drug discovery: medicinal chemistry, structure–activity relationships, and translational perspectives
作者
Aashik Malik; Md Arif Naseer; Mayank Yadav; Zulphikar Ali; Jai Parkash Kadian展开收起
作者单位
1. Adarsh Vijendra Institute of Pharmaceutical Sciences, Shobhit University, Gangoh, India展开收起
81
天
Azole chroman-4-one, tetralone and chromen-4-one derivatives: synthesis, Mycobacterium tuberculosis CYP121A1 enzyme inhibition and antimycobacterial activity
作者
Jabril M. Abdali; Lama A. Alshabani; Alistair K. Brown; Amit Kumar; Sam Wilcocks; Ahmed Y. G. Alhejaili; Sanjida Y. Kalam; D. Fernando Estrada; Claire Simons展开收起
作者单位
1. School of Pharmacy & Pharmaceutical Sciences, Cardiff University, Cardiff, U.K.; 2. Pharmaceutical Sciences Department, College of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia; 3. Pharmaceutical Sciences Department, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, Saudi Arabia; 4. Bioscience Institute, University of Newcastle, Newcastle upon Tyne, U.K.; 5. Department of Biochemistry, Jacobs School of Medicine and Biomedical Science, University at Buffalo, Buffalo, U.S.A.; 6. London School of Hygiene & Tropical Medicine, London, U.K.; 7. Brunel University London, Uxbridge, U.K.展开收起
77
天
From danger to resolution: targeting purinergic signaling in CNS diseases
作者
Camille Degryse; Kirti Gupta; Luc Buée; Thierry Burnouf; David Blum; Ming-Li Chou展开收起
作者单位
1. Lille Neuroscience & Cognition (LilNCog), UMR-S1172, Inserm, University of Lille, CHU Lille, Lille, France; 2. International Ph.D. Program in Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan; 3. NeuroTMULille, University of Lille, Lille, France; 4. Graduate Institute of Biomedical Materials and Tissue Engineering, College of Biomedical Engineering, Taipei Medical University, New Taipei City, Taiwan; 5. International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, New Taipei City, Taiwan; 6. NeuroTMULille, Taipei Medical University, Taipei, Taiwan展开收起
8
天
Vepdegestrant: the first FDA-approved oral PROTAC and a milestone in targeted protein degradation
作者
Jeffrey Yang; Longqin Hu展开收起
作者单位
1. Hansoh Bio, LLC, Rockville, USA; 2. Department of Medicinal Chemistry, Ernest Mario School of Pharmacy, Rutgers, The State University of New Jersey, Piscataway, USA; 3. Rutgers Cancer Institute, New Brunswick, USA展开收起
179
天
Pantoprazole as a potential repurposed drug targeting the adenosinergic system in esophageal cancer
作者
Adriana Simioni; Rafael D Weimer; Julia B de Souza; Isadora V Citrini; Julia A da Rosa; Kaline Cardoso; Maria E Delawi; Luis FSM Timmers; Fernanda B Morrone展开收起
作者单位
1. Laboratório de Farmacologia Aplicada, Escola de Ciências da Saúde e da Vida, PUCRS, Porto Alegre, Brasil; 2. Programa de Pós-graduação em Biologia Celular e Molecular, Escola de Ciências da Saúde e da Vida, PUCRS, Porto Alegre, Brasil; 3. Programa de Pós-graduação em Medicina e Ciências da Saúde, Escola de Medicina, PUCRS, Porto Alegre, Brasil; 4. Programa de Pós-graduação em Biotecnologia, Univates, Lajeado, Brasil; 5. Programa de Pós-graduação em Ciências Médicas, Univates, Lajeado, Brasil展开收起
35
天
An updated review of enantioselective syntheses and biological actions of carbanucleosides
作者
Sheila I. de Diego Saadia; Sergio H. Szajnman; Juan B. Rodriguez展开收起
作者单位
1. Departamento de Química Orgánica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Ciudad Universitaria, Buenos Aires, Argentina; 2. CONICET-Universidad de Buenos Aires, Unidad de Microanálisis y Métodos Físicos en Química Orgánica (UMYMFOR), Buenos Aires, Argentina展开收起
FAQ
MEDICINAL CHEMISTRY RESEARCH审稿要多久?
截至2026-11-19,CrushSCI 收录了 MEDICINAL CHEMISTRY RESEARCH 的 21 篇完整审稿记录。最快一篇从收稿到录用用了 4 天(Centanafadine (Simtriyo®): a first-in-class triple reuptake inhibitor approved for attention-deficit/hyperactivity disorder (ADHD),2026-08-08 收稿,2026-08-12 录用),最慢一篇用了 179 天;平均 52.4 天,中位数 38 天。最快这篇的日期间隔异常短,建议点开原文核对。
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。
